Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the first quarter ended June 30, 2023, after the close of market on Wednesday, July 26, 2023.

The release will be accessible on Taro’s website at www.taro.com.

About Taro Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

William J. Coote VP, Chief Financial Officer (914) 345-9001 William.Coote@taro.com

Grafico Azioni Taro Pharmaceutical Indu... (NYSE:TARO)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Taro Pharmaceutical Indu...
Grafico Azioni Taro Pharmaceutical Indu... (NYSE:TARO)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Taro Pharmaceutical Indu...